Vaccine News and Research

Latest Vaccine News and Research

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization met with the CEOs of leading vaccine manufacturing companies to discuss strategies to improve the access to COVID-19 vaccines, especially in low- and lower middle-income countries and in Africa.

20 Sep 2021

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology (ESMO Congress 2021), the leading professional society for medical oncology.

20 Sep 2021

A novel FACS-based approach for SARS-CoV-2 serology

A recent study discusses a simple, sensitive, and quantitative serological test based on FACS assay to evaluate antibodies against SARS-CoV-2.

20 Sep 2021

Asymptomatic SARS-CoV-2 infections vary with age and geographical location

In this study, surveillance data were used to investigate how asymptomatic SARS-CoV-2 infections vary by age and geographic location.

20 Sep 2021

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

The test results that hot day in early August shouldn’t have surprised me — all the symptoms were there. A few days earlier, fatigue had enveloped me like a weighted blanket. I chalked it up to my weekend of travel. Next, a headache clamped down on the back of my skull.

20 Sep 2021

Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion

Researchers from the University of Southern California investigated mutations in the N-terminal and RBD domains of the spike protein.

20 Sep 2021

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Scientists have addressed the gap in the research regarding the adverse reactions to the COVID-19 vaccine among individuals with allergies.

20 Sep 2021

First dose of COVID-19 mRNA vaccine (BNT162b2) reduced platelet polyP levels in young females

In a recent study, scientists have tested the hypothesis that indicates the role of polyP in the COVID-19 mRNA vaccine-induced immune responses.

20 Sep 2021

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine.

20 Sep 2021

Myocarditis risk from mRNA COVID vaccines re-evaluated in Canadian study (Research Now Withdrawn)

Scientists from the University of Ottawa, Canada, have recently estimated the prevalence of myocarditis/pericarditis in individuals recently immunized with mRNA-based coronavirus disease 2019 (COVID-19) vaccines. The analysis reveals a prevalence of 10 myopericarditis cases for every 10,000 vaccine doses. The study is currently available on the medRxiv* preprint server.

20 Sep 2021

New QCovid tool helps identify vaccinated groups at highest risk of Covid-19 hospitalization and death

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalization or death from 14 days post the second dose vaccination, when substantial immunity should be expected.

20 Sep 2021

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.

20 Sep 2021

Vaccine News and Research

Latest Vaccine News and Research

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

A novel FACS-based approach for SARS-CoV-2 serology

Asymptomatic SARS-CoV-2 infections vary with age and geographical location

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

First dose of COVID-19 mRNA vaccine (BNT162b2) reduced platelet polyP levels in young females

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Myocarditis risk from mRNA COVID vaccines re-evaluated in Canadian study (Research Now Withdrawn)

New QCovid tool helps identify vaccinated groups at highest risk of Covid-19 hospitalization and death

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

Characterizing the flexibility of SARS-CoV-2 variant of concern spike proteins

Analysis of 2021 Ebola outbreak reveals long-term dormant infections

Development of a potential pan-variant aerosol to manage COVID-19

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

Combining antibody markers to improve serosurveillance for SARS-CoV-2

Study shows efficacy of mRNA vaccines against SARS-CoV-2 in individuals with obesity

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in